BioSpace is the leading online source for biotechnology jobs, breaking industry news, and expert analysis. It serves as the digital hub for life science news and jobs, connecting innovative organizations and talented professionals in the life sciences industry. BioSpace provides essential insights, opportunities, and tools to advance health and quality of life globally.

BioSpace

Modular Medical focuses on providing tools to help healthcare providers manage diabetes care more effectively. The company's product, MODD1, is designed to simplify diabetes management.

Modular Medical

BioSpace Pro Recruitment Services

Hotbed Maps

BioSpace serves as the leading online source for biotechnology jobs, breaking industry news and expert analysis. BioSpace has accelerated recruitment, communication and discovery among business and scientific leaders within the life sciences for more than 30 years.

Looking for a new job? Find biotech, clinical research and pharmaceutical jobs from thousands of employers. BioSpace has new positions posted daily. Apply today!
https://hubs.li/Q026jbFX0

Bristol Myers Squibb's experimental two-part formulation hit its two primary endpoints and a key secondary endpoint in a Phase III study.
#BristolMyersSquibb #BMS #KidneyCancerTreatment #BioSpace
https://hubs.li/Q026j8v60

Amgen's bispecific T-cell engager is showing promise for small cell lung cancer.
#Amgen #LungCancerResearch #CancerResearch #BioSpace
https://hubs.li/Q026h6ZY0

Keep up with the FDA's latest rulings on novel drugs and expanded indications. 
#FDA #DrugDevelopment #DrugDiscovery #Pharma #BioSpace
https://hubs.li/Q026gTxN0

Laronde and Senda Biosciences merged on Thursday forming a new company called Sail Biomedicines.
#Laronde #SendaBiosciences #SailBiomedicines #Biomedicines #BioSpace
https://hubs.li/Q026gWPY0

The {{linkedin_mention(urn:li:organization:1809|European Commission)}} unconditionally approved {{linkedin_mention(urn:li:organization:1185|Pfizer)}}'s proposed $43 billion acquisition of antibody-drug conjugate company {{linkedin_mention(urn:li:organization:21407|Seagen)}}.
#EuropeanCommission #Pfizer #Seagen #Biotech #BioSpace
https://lnkd.in/g5Gh_7hx

Merck closed a deal potentially worth $22 billion across three of Daiichi Sankyo, Inc.'s DXd antibody-drug conjugates for various solid tumor indications.
#Merck #DaiichiSankyo #DrugDevelopment #Pharma #BioSpace
https://hubs.li/Q026gLVv0

BioSpace's latest report explores the benefits of using AI tools in recruitment and provides recommendations for HR and talent acquisition professionals to leverage AI effectively. Download the report today! 
https://hubs.li/Q0231bK-0

Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
#LayoffTrends #JobCuts #Biotech #Pharma #BioSpace
https://hubs.li/Q02669100

Royalty Pharma announced a $1 billion upfront payment to PTC Therapeutics, Inc. for additional royalties in Evrysdi, licensed and marketed by Roche. 
#RoyaltyPharma #PTCTherapeutics #Evrysdi #Roche #BioSpace
https://hubs.li/Q0266qP40

Metric
Company Name	BioSpace	Modular Medical
Symbol
MSH ID	COM:BIOSPACE	COM:MODULARMEDICAL
Market	PRIVATE	PRIVATE
Sector	Life Sciences	Healthcare & Health Services
Industry	Internet News	Medical Devices
Country	US	US
Stage	Series B	Post-IPO Equity
Employee Count
Website	biospace.com	modularmedical.com
LinkedIn	biospaceinc	modular-medical
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	698.15K	1.18K
Web Traffic Growth	-0.20	1.72
Valuation
Raised Capital	10M	8.20M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	94.47
28-Day Growth Score	26.83
90-Day Growth Score	73.50
365-Day Growth Score	77.40

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BIOSPACE

BioSpace

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue